SUSTAINED VIRAL RESPONSE AND SAFETY OF MK-7009 IN CIRRHOTIC TREATMENT-EXPERIENCED PATIENTS WITH GENOTYPE 1 HCV INFECTION WHO HAVE FAILED PREVIOUS PEGYLATED INTERFERON AND RIBAVIRIN TREATMENT

被引：1
|
作者：
Rodriguez-Torres, M. [1 ]
Stoehr, A. [2 ]
Gane, E. [3 ]
Serfaty, L. [4 ]
Lawitz, E. [5 ]
Bourque, M. [6 ,7 ]
Bhanja, S. [6 ,7 ]
Barnard, R. [6 ,7 ]
Hwang, P. [6 ,7 ]
Mobashery, N. [6 ,7 ]
机构：
[1] Fdn Invest Diego, San Juan, PR USA
[2] IFI Inst Interdisziplinare Med, Hamburg, Germany
[3] Auckland Clin Studies Ltd, Auckland, New Zealand
[4] Univ Paris 06, Serv Hepatol, Paris, France
[5] Alamo Med Res, San Antonio, TX USA
[6] Merck Sharp & Dohme Corp, West Point, PA USA
[7] Merck Sharp & Dohme Corp, N Wales, PA USA
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60108-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
106
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [11] Pegylated interferon and Ribavirin for the treatment of HCV patients who failed prior therapy: Racial and genotype differences
    Gaglio, PJ
    Brown, MJ
    Brown, RS
    GASTROENTEROLOGY, 2002, 123 (01) : 73 - 73
  • [12] MK-7009 SIGNIFICANTLY IMPROVES RAPID VIRAL RESPONSE (RVR) IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C (CHC) GENOTYPE 1 INFECTION
    Manns, M. P.
    Gane, E.
    Rodriguez-Torres, M.
    Stoehr, A.
    Yeh, C. -T
    Wiedmann, R.
    Hwang, P.
    Quirk, E.
    Silber, J.
    Lee, A.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S384 - S384
  • [13] Sustained virologic response in treatment-experienced patients with HCV genotype 1 is increased by simeprevir
    Nature Reviews Gastroenterology & Hepatology, 2014, 11 (1) : 2 - 2
  • [14] SAFETY AND EFFICACY OF VANIPREVIR (MK-7009) IN COMBINATION WITH PEG-INTERFERON ALFA-2A (PEG-IFN)/RIBAVIRIN (RBV) IN GENOTYPE 1 TREATMENT EXPERIENCED HCV-INFECTED JAPANESE PATIENTS
    Hayashi, Norio
    Nakamura, Keisuke
    Wright, Duncan Hamish
    Caro, Luzelena
    Barnard, Richard J.
    Mobashery, Niloufar
    Tanaka, Yoshiyuki
    HEPATOLOGY, 2011, 54 : 996A - 996A
  • [15] TMC435 IN HCV GENOTYPE 1 PATIENTS WHO HAVE FAILED PREVIOUS PEGYLATED INTERFERON/RIBAVIRIN TREATMENT: FINAL SVR24 RESULTS OF THE ASPIRE TRIAL
    Zeuzem, S.
    Berg, T.
    Gane, E.
    Ferenci, P.
    Foster, G. R.
    Fried, M. W.
    Hezode, C.
    Hirschfield, G.
    Jacobson, I.
    Nikitin, I.
    Pockros, P.
    Poordad, F.
    Lenz, O.
    Peeters, M.
    Sekar, V.
    De Smedt, G.
    Beumont-Mauviel, M.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S1 - S2
  • [16] TMC435 in HCV Genotype 1 Patients Who Have Failed Previous Pegylated Interferon/Ribavirin Treatment: Final SVR24 Results of The ASPIRE Trial
    Poordad, F.
    Zeuzem, S.
    Berg, T.
    Gane, E.
    Ferenci, P.
    Foster, G.
    Fried, M. W.
    Hezode, C.
    Hirschfield, G.
    Jacobson, I. M.
    Nikitin, I.
    Pockros, P. J.
    Lenz, O.
    Peeters, M.
    Sekar, V.
    De Smedt, G.
    Beumont-Mauviel, M.
    GASTROENTEROLOGY, 2012, 142 (05) : S161 - S161
  • [17] IMPACT OF IL28B GENOTYPE ON VIROLOGIC RESPONSE IN PRIOR TREATMENT FAILURE PATIENTS WHO RECEIVED MK-7009 IN COMBINATION WITH PEGINTERFERON AND RIBAVIRIN
    Mobashery, N.
    Wong, P.
    Zhang, S.
    Bhanja, S.
    Warner, A.
    Shaw, P. M.
    Rodriguez-Torres, M.
    Gane, E. J.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S467 - S467
  • [18] SOFOSBUVIR PLUS RIBAVIRIN, AN INTERFERON-FREE REGIMEN, IN THE TREATMENT OF TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH CHRONIC GENOTYPE 4 HCV INFECTION
    Ruane, P. J.
    Ain, D.
    Meshrekey, R.
    Riad, J.
    Soliman, M.
    Mikhail, S.
    Wolfe, P. R.
    Kersey, K.
    Doehle, B.
    Jiang, D.
    Symonds, W. T.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S503 - S504
  • [19] Safety and Sustained Viral Response of MK-5172 for 12 Weeks in Combination With Pegylated Interferon Alfa-2B and Ribavirin for 24 Weeks in HCV Genotype 1 Treatment-Naive Noncirrhotic Patients
    Marcellin, Patrick
    Vierling, John M.
    Bacon, Bruce R.
    Manns, Michael P.
    Fandozzi, Christine M.
    Gress, Jacqueline
    Gilbert, Christopher L.
    Hwang, Peggy
    Wahl, Janice
    Cooreman, Michael
    Mobashery, Niloufar
    HEPATOLOGY, 2012, 56 : 561A - 561A
  • [20] VIRAL KINETIC RESPONSE TO 12 WEEK TREATMENT WITH ROSIGILITAZONE IN CHRONIC HEPATITIS C, GENOTYPE 1 PATIENTS WHO ARE PREVIOUS RELAPSERS OR NONRESPONDERS TO PEGYLATED INTERFERON AND RIBAVIRIN
    Mills, Shane J.
    Naus, Rhonda J.
    Barstow, Karol
    Harrison, Stephen
    HEPATOLOGY, 2008, 48 (04) : 1145A - 1146A
12345